AG18
CAS No. 118409-57-7
AG18 ( RG-50810; RG-50858; TX 825; Tyrphostin 23; Tyrphostin AG-18 )
Catalog No. M10624 CAS No. 118409-57-7
AG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 49 | In Stock |
|
25MG | 112 | In Stock |
|
50MG | 212 | In Stock |
|
100MG | 320 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAG18
-
NoteResearch use only, not for human use.
-
Brief DescriptionAG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
-
DescriptionAG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
-
SynonymsRG-50810; RG-50858; TX 825; Tyrphostin 23; Tyrphostin AG-18
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number118409-57-7
-
Formula Weight186.17
-
Molecular FormulaC10H6N2O2
-
Purity>98%(HPLC)
-
SolubilityEthanol: 37 mg/mL (198.74 mM); DMSO: 37 mg/mL (198.74 mM)
-
SMILESN#C/C(C#N)=C/C1=CC=C(O)C(O)=C1
-
Chemical Name2-[(3,4-dihydroxyphenyl)methylene]-propanedinitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gazit A, et al. J Med Chem, 1989, 32(10), 2344-2352.
molnova catalog
related products
-
ZD-4190
ZD-4190 is a inhibitor of the vascular endothelial cell growth factor receptor 2 (VEGFR2) and of epidermal growth factor receptor (EGFR) signalling used for the treatment of cancer.
-
R162
R162 is an effective glutamate dehydrogenase 1 (GDH1) inhibitor.
-
AZD-9291 dimesylate
A potent, selective, third-generation irreversible inhibitor of mutant EGFR with IC50s of 1/12/5 nM for L858R-T790M/L858R/L861Q respectively.